QuickMD

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• LiraglutideFDA-approved
• SemaglutideType not stated

What they publish

QuickMD publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

$99 per visit, with no membership required (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States no insurance is required and no memberships are needed.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• No membership at all — you pay per visit, so there is no recurring charge to cancel.
• Covers liraglutide, a daily GLP-1 that predates semaglutide and is frequently cheaper. Most services do not mention it.
• The visit fee excludes medication, which you fill separately.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• The $99 is the visit only — establish the medication cost separately.
• Liraglutide is a daily injection rather than weekly, which suits some people and not others.
• Ask whether any compounded product is involved.